Exousia Pro, Inc. (MAJI)

OTCMKTS · Delayed Price · Currency is USD
0.0300
+0.0007 (2.37%)
Mar 5, 2026, 3:44 PM EST
Market Cap1.32M +17.7%
Revenue (ttm)-12.83K
Net Income-661.35K
EPS-0.02
Shares Out44.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume203,500
Average Volume240,866
Open0.0337
Previous Close0.0293
Day's Range0.0250 - 0.0337
52-Week Range0.0240 - 0.3199
Beta-4.96
RSI37.66
Earnings DateJun 18, 2026

About Exousia Pro

Exousia Pro, Inc., a clinical stage biotechnology company, develops ways to exploit the therapeutic potential of exosomes for the field of oncology in the United States. The company was formerly known as Marijuana, Inc. and changed its name to Exousia Pro, Inc. in April 2025. Exousia Pro, Inc. was incorporated in 2010 and is based in Saint Petersburg, Florida. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol MAJI
Full Company Profile

Financial Performance

Financial Statements